Results 61 to 70 of about 53,706 (285)

PERFIL DE MORTALIDADE POR SARCOMA DE KAPOSI NO BRASIL: UMA ANÁLISE DO PERÍODO DE 1996 A 2022

Revista Científica Eletrônica do Conselho Regional de Farmácia da Bahia
RESUMO: O Sarcoma de Kaposi (SK), é uma doença sistêmica, de acometimento cutâneo, que ganhou maior evidência a partir de 1980, com o surgimento da síndrome da imunodeficiência adquirida.
Ana Flávia Souto Figueiredo Nepomuceno, Mariana Souto Figueiredo   +1 more
semanticscholar   +1 more source

HIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS. [PDF]

, 2016
Kaposi's sarcoma (KS) in HIV-infected individuals can have a wide range of clinical outcomes, from indolent skin tumors to a life-threatening visceral cancer. KS tumors contain endothelial-related cells and inflammatory cells that may be HIV-infected. In
Barbier, Andrew E, Fogel, Gary B, Lamers, Susanna L, McGrath, Michael S, Nolan, David J, Rose, Rebecca, Salemi, Marco   +6 more
core   +4 more sources

SARCOMA DE KAPOSI EN PACIENTE VIH. INFORME DE CASO

La Ciencia al Servicio de la Salud y Nutrición
Introducción: La infección por el Virus de Inmunodeficiencia Humana fue identificada como el agente causal del Síndrome de Inmunodeficiencia Adquirida en la década de los 80.
Eida Ortiz Zayas, Mónica Yambay Latta, Rolando Teruel Ginés, María de los Ángeles Leyva Montero, Rubén Andrés Ullauri Carballo   +4 more
semanticscholar   +1 more source

Speculations on the clinical significance of asymptomatic viral infections [PDF]

, 2016
A detailed understanding of asymptomatic chronic viral infections is critical to analyse their pathogenesis, assess the severity and burden of disease and, where required, optimize public health control measures.
Gentile, Giuseppe, Micozzi, Alessandra
core   +1 more source

Loss of primary cilia promotes EphA2‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment

Molecular Oncology, EarlyView.
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho, Yubin Hah, Eunsik Yun, Hye In Ka, Aram Lee, Sora Han, Dawn Lee, Sung Wook Kim, Jong Hoon Park, Byung Su Kwon, Young Yang, Jongmin Kim   +11 more
wiley   +1 more source

Conjunctival Kaposi's Sarcoma. An Unusual AIDS Presentation [PDF]

, 2003
O sarcoma de Kaposi ocular isolado surge em 0,3% a 5% dos doentes com SIDA, mas, em doentes com tumor disseminado, esta incidência aumenta para 15% a 20%. Apresentamos um caso de sarcoma de Kaposi epidémico, mucocutâneo, cuja primeira manifestação foi
Carmona, M, Castro, A, Horta, A, Pinheiro, S, Ramos, N, Serra, MJ, Simões, H   +6 more
core  

Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study [PDF]

, 2003
Background: Infection with human herpesvirus 8 (HHV-8) is the necessary causal agent in the development of Kaposi's sarcoma (KS). Infection with HIV-1, male gender and older age all increase risk for KS.
BM Friedman, C Boshoff, C Boshoff, D Serraino, D Whitby, DH Kedes, Dimitra Bourboulia, EP Zorrilla, F Sitas, F Vitale, Freddy Sitas, G de-The, G de-The, G Rezza, GR Simpson, H Renwick, J Iscovich, J Ziegler, Janet M Wojcicki, JJ Goedert, JL Ziegler, JL Ziegler, KA Staskus, L Rainbow, Lara Stein, LD Baker, M Dedicoat, Margaret I Urban, Martin Hale, Moosa Patel, P Cook-Mozaffari, P Kellam, Paul Ruff, PS Moore, R Greenblatt, R Newton, R Newton, R Tedeschi, Ranjan Sur, RJ Biggar, Rob Newton, RP Stowe, S Lemeshow, S Plancoulaine, SJ Gao, STATA, Statistics South Africa, TH Bothwell, TH Bothwell, VR Gordeuk, Y Chang, Z Grossman   +51 more
core   +2 more sources

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

Advanced Functional Materials, EarlyView.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth, Neal I. Callaghan, Locke Davenport Huyer   +2 more
wiley   +1 more source

Sarcoma de Kaposi em Paciente Jovem Imunocompetente: uma Quinta Variante Epidemiológica?

Revista Brasileira de Cancerologia, 2019
Introdução: O sarcoma de Kaposi apresenta, classicamente, quatro tipos de variantes: clássico, endêmico, associado à imunossupressão (ou iatrogênico) e epidêmico (ou relacionado à Aids).
Fernando Augusto Batista Campos, Karen Bento Ribeiro, Cristina da Cunha Hueb Barata de Oliveira, Jane Monteiro de Godoy Bernardes, Marcus Aurelho de Lima   +4 more
doaj   +1 more source

Sarcoma de Kaposi rectal en paciente VIH con respuesta clínica completa

Oncología Clínica, 2022
El sarcoma de Kaposi es una neoplasia compleja de origen mesenquimal, asociada al herpes virus humano tipo 8, que normalmente coincide con una alteración inmunológica que promueve un medio ambiente ideal para su desarrollo.
Jacqueline Becker, María Florencia Prieto, S. Iseas, Mariana Coraglio   +3 more
semanticscholar   +1 more source